Journal of Medical Oncology

Commentary: J Med Oncol (1-2)

Integrating Genomics, AI and Immunotherapy for Personalized Cancer Care

Author(s): Almaeen Faderl

Full-Text | PDF

Brief Report: J Med Oncol (1-2)

The Tumor Immune Microenvironment as a Therapeutic Target in Oncology

Author(s): Ouyang Elango

Full-Text | PDF

Opinion Article: J Med Oncol (1-2)

Molecular Mechanisms of Resistance to Targeted Cancer Therapy

Author(s): Wheler Thieblemont

Full-Text | PDF

Perspective Article: J Med Oncol (1-2)

Liquid Biopsies as the Next Standard in Cancer Screening and Surveillance

Author(s): Bonneville Iquebal

Full-Text | PDF

Short Communication: J Med Oncol (1-2)

Neoantigen Vaccines: Personalized Immunotherapy for Durable Cancer Control

Author(s): Breckpot Schreiber

Full-Text | PDF